TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 80.28M | 77.06M | 75.32M | 71.22M | 69.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.28M | 77.06M | 75.32M | 71.22M | 69.30M |
| Cost of Revenue | 25.55M | 24.87M | 24.25M | 23.17M | 22.43M |
| Gross Profit | 54.72M | 52.19M | 51.08M | 48.04M | 46.87M |
| SG&A Expenses | 78.88M | 78.15M | 79.13M | 78.47M | 79.37M |
| Depreciation & Amortization | 380.00K | 380.00K | 380.00K | 380.00K | 380.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 114.03M | 112.52M | 112.60M | 110.98M | 111.00M |
| Operating Income | -33.76M | -35.46M | -37.27M | -39.76M | -41.70M |
| Income Before Tax | -38.60M | -39.06M | -40.83M | -43.54M | -37.99M |
| Income Tax Expenses | 230.00K | -59.00K | -59.00K | -92.00K | -144.00K |
| Earnings from Continuing Operations | -38.83 | -39.00 | -40.77 | -43.44 | -37.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.83M | -39.00M | -40.77M | -43.44M | -37.84M |
| EBIT | -33.76M | -35.46M | -37.27M | -39.76M | -41.70M |
| EBITDA | -32.75M | -34.41M | -36.21M | -38.72M | -40.68M |
| EPS Basic | -0.83 | -0.89 | -1.12 | -1.41 | -1.39 |
| Normalized Basic EPS | -0.51 | -0.56 | -0.70 | -0.88 | -1.06 |
| EPS Diluted | -0.83 | -0.89 | -1.12 | -1.41 | -1.39 |
| Normalized Diluted EPS | -0.51 | -0.56 | -0.70 | -0.88 | -1.06 |
| Average Basic Shares Outstanding | 187.74M | 176.13M | 155.41M | 134.71M | 114.02M |
| Average Diluted Shares Outstanding | 187.74M | 176.13M | 155.41M | 134.71M | 114.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |